NPPA not to intervene in commercial issues regarding authorized dealership Medical Dialogues Team30 Nov 2021 6:12 PM ISTNew Delhi: Through a recently issued office memorandum, the National Pharmaceutical Pricing Authority (NPPA) has clarified that commercial issues,...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study Medical Dialogues Team29 Nov 2021 6:21 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
How to register medical devices? CDSCO issues guidelines Medical Dialogues Team28 Nov 2021 11:30 AM ISTNew Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has specified the documentation required for medical...
JnJ gets CDSCO panel nod for COVID vaccine study in 12-17 year old Medical Dialogues Team27 Nov 2021 5:59 PM ISTNew Delhi: In order to achieve the unmet medical need in the treatment of COVID-19, the Subject Expert Committee (SEC) functional under the Central...
Pfizer gets CDSCO panel nod to study PF-07321332 for COVID treatment Medical Dialogues Team26 Nov 2021 7:09 PM ISTNew Delhi: In a significant development, pharmaceutical major Pfizer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 6:02 PM ISTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Sun Pharma Dapagliflozin, Glimepiride, Metformin FDC gets CDSCO panel nod for phase 3 trial Medical Dialogues Team24 Nov 2021 6:28 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel allows Novartis to waiver conditions for study of anti malarial drug Cipargamin Medical Dialogues Team23 Nov 2021 5:59 PM ISTNew Delhi: Based on the justification provided by the pharma major Novartis, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC Medical Dialogues Team22 Nov 2021 5:34 PM ISTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
Patent Infringement: GSK moves court against Glenmark over Vilor F Medical Dialogues Team20 Nov 2021 4:51 PM ISTNew Delhi: Coming down on Glenmark Pharmaceuticals, British drug maker GlaxoSmithKline has filed a patent infringement case in the Delhi High Court...
CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
